In viva antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 3, 1998, Pages 185-192

  Yamada, Haruki ^a   Nagai, Takayuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Adjuvant; Bronchial asthma; Influenza vaccine; Influenza virus; Mucosal immunity; Sho seiryu to

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KAMPO; SHO SEIRYU TO; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; HERBACEOUS AGENT; SHO-SEIRYU-TO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HERBAL MEDICINE; IMMUNE SYSTEM; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LUNG LAVAGE; LYMPHOCYTE; MOUSE; MUCOSA; NONHUMAN; VIRUS REPLICATION; ANIMAL; CHINESE MEDICINE; DRUG EFFECT; MUCOSAL IMMUNITY; REVIEW;

ANIMALS; ANTIVIRAL AGENTS; DRUGS, CHINESE HERBAL; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MEDICINE, CHINESE TRADITIONAL; MICE;

EID: 0031595520     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Murphy B.R., Webster, R.G. Orthomyxoviruses. In: Virology. Fields, B.N., Knipe, D.M. (Eds.). Raven Press: New York 1990, 1091-152.
2. Smith, F.I., Palese, P. Variation in influenza virus genes: Epidemiological, pathogenic, and evolutionary consequences. In: The Influenza Viruses, Krung, R.M. (Ed.). Plenum Press: New York 1989, 319-59.
3. Hirsch, M.S., Kaplan, J.C. Antiviral agents. In: Virology. Fields, B.N., Knípe, D.M. (Eds.). Raven Press: New York 1990, 441-68.
4. Tamura, S.-I., Funato, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C., Kurata, T. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur I Immunol 1991, 21: 1337-44.
5. Nagai, T., Yamada, H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to" and its mode of action. Int J Immunopharmacol 1994, 16: 605-13.
6. Kurokawa, M., Imakita, M., Kumeda, C.A., Yukawa, T.A., Shiraki, K. Kakkon-to suppressed interleukin-1α production responsive to Interferon and alleviated influenza infection in mice. J Traditional Med 1996, 13: 201-9.
7. Tamura, S.-I., Asanuma, H., Ito, Y. et al. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 1992, 22: 477-81.
8. Clements, M.L., Betts, R.F., Tierney, E.L., Murphy, B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986, 24: 157-60.
9. Kris, R.M., Asofsky, R., Evans, C.B., Small, P.A., Jr. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol 1985, 134: 1230-5.
10. Waldman, R.H., Wigley, F.M., Small, P.A., Jr. Specificity of respiratory secretion antibody against influenza virus. J Immunol 1970, 105: 1477-83.
11. Richman, D.D., Murphy, B.R., Tierney, E.L., Chanock. R.M. Specificity of the local secretory antibody to influenza A virus infection. J Immunol 1974, 113: 1654-6.
12. Shvartsman, Y.S., Agranovskaya, E.N., Zykov, M.P. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. J Infect Dis 1977, 135: 697-705.
13. Liew, F.Y., Russel, S.M., Appleyard, G., Brand, C.M., Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T-cell reactivity. Eur J Immunol 1984, 14: 350-6.
14. Nagai, T., Urata, M., Yamada, H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to": Effects on aged mice, against subtypes of A viruses and B virus, and therapeutic effect. Immunopharmacol Immunotoxicol 1996, 18: 193-208.
15. Nagai, T., Matsumoto, T., Yamada, H. In vivo anti-influenza virus activity of Kampo medicine "Sho-seiryu-to": effect to Peyer's patch cells and antiviral activity on pulmonary inflammation model mouse. J Traditional Med 1996, 13: 328-9.
16. Hirabayashi, Y., Kurata, H., Funato, H. et al. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990, 8: 243-8.
17. Rudzik, R., Clancy, R.L., Perey, D.Y.E., Day, R.P., Bienenstock, J. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patch and bronchial lymphocytes. J Immunol 1975, 114: 1599-604.
18. McDermott, M.R, Bienenstock, J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J Immunol 1979, 122: 1892-8.
19. Weisz-Carrington, P., Roux, M.E., McWilliams, M., Phillips-Quagliata, J.M., Lamm, M.E. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: Evidence for a generalized secretory immune system, J Immunol 1979, 123: 1705-8.
20. Asanuma, H., Thompson, A.H., Iwasaki, T. et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 1997, 202: 123-31.
21. Kumagai, A. Kampo and the treatment of allergy. In: Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicines. Hosoya, E., Yamamura, Y. (Eds.). Excerpta Medica: Amsterdam 1988, 237-8.
22. Takeuchi. Y., Kimura. Y. Antiallergic effect of Sho-seiryu-to (TJ-19). In: Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicines. Hosoya, E., Yamamura, Y. (Eds.). Excerpta Medica: Amsterdam 1988, 259-65.
23. Sone, H., Komatsu, Y., Aburada, M., Hosoya, E. Mechanism of action of Sho-seiryu-to (TJ-19). In: Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicines. Hosoya, E., Yamamura, Y. (Eds.). Excerpta Medica: Amsterdam, 1988, 266-71.
24. Hazama, M., Mayumi-Aono, A., Miyazaki, T., Hinuma, S., Fujisawa, Y. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology 1993, 78: 643-9.